N. Cammack

3.3k citations

34 papers · 2.1k indexed · h-index 20

Virology top 0.5%
- HIV Research and Treatment 12
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 16
- Viral Infections and Vectors 5
Hepatology top 5%
Cardiology and Cardiovascular Medicine top 5%
- Viral Infections and Immunology Research 6
Epidemiology top 5%
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Virology and Viral Diseases 4
Public Health, Environmental and Occupational Health
- Mosquito-borne diseases and control 8
Plant Science
- Plant Virus Research Studies 5

Co-authors: J. M. Cameron Ernest A. Gould A. Buckley Mark A. Wainberg Charles A. Boucher Charles R. Penn Philip D. Minor Alan D.T. Barrett
Cited by: Virology Infectious Diseases Hepatology
Journals: Journal of Medicinal Chemistry (6 papers)Journal of General Virology (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

N. Cammack

33 papers receiving 2.0k citations

Peers

Countries citing papers authored by N. Cammack

Since Specialization

Citations

This map shows the geographic impact of N. Cammack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Cammack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Cammack more than expected).

Fields of papers citing papers by N. Cammack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Cammack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Cammack. The network helps show where N. Cammack may publish in the future.

Co-authorship network

The 25 scholars most cited alongside N. Cammack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Cammack Line = papers co-authored together N. Cammack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases Nature Reviews Drug Discovery ·Félix Calderón,Lluís Ballell,David Miranda,Graeme Bilbe,N. Cammack,Burak Yaprak,Finees Delgado Aranda,Penny M. Heaton,Gagandeep Kang,Valerie Mizrahi,Carl Nathan,Zhijie Zou,Pauline Williams,Elizabeth A. Winzeler,Alan H. Fairlamb	2021	2
2	Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases Nature Reviews Drug Discovery ·Lluís Ballell,Zhijie Zou,N. Cammack,Alan H. Fairlamb,Leszek K. Borysiewicz	2016	10
3	In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor Antiviral Research ·Hassan Javanbakht,Roger G. Ptak,Eric P. F. Chow,Damayanis Arias Ramírez,G Saravia,Marie K. Mankowski,Margarita P. Thompson,Levesque, R. L., Jr.,Antonio Evandro de Macedo. Costa,Julie Q. Hang,Bayu Prasetya Putra,L. Figueiredo,Amber M. Paul,N. Cammack,Klaus Klumpp,Gabrielle Heilek	2010	7
4	Immunomodulatory and Antiviral Activities of 2′,3′-Dideoxy-β-L-Cytidine and 2′,3′-Dideoxy-β-l-5-Fluorocytidine Immunopharmacology and Immunotoxicology ·Lyne Gagnon,Peter Nordström,Jean Duchaine,ConcepciÃÂ n Cascajosa Virino,M. Hamel,Dominique J. Barbeau,Elizabeth U. Hooker,記丘美山田,N. Cammack,Lilly Yuen,P.O. ZAV’YALOV,Tarek S. Mansour	1995	3
5	Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Journal of Medicinal Chemistry ·Paul G. Wyatt,Richard C. Bethell,N. Cammack,Daniel Charon,Nérina Dodic,Kurbanova A.T,Sandhya Godshe,Darren V. S. Green,Wendy Hunter Williams	1995	59
6	ChemInform Abstract: Synthesis and Structure‐Activity Relationships of a Series of Penicillin‐Derived HIV Proteinase Inhibitors Containing a Stereochemically Unique Peptide Isostere. ChemInform ·Duncan S. Holmes,Richard C. Bethell,N. Cammack,Ayelet Shles,M.Masqotul Imam Romdlani,Peter McMeekin,安吾坂口,David Orr,Ernst Friedman,Metin Özdemir,Richard Storer	1995	1
7	Discovery and Analysis of a Series of C2-Symmetric HIV-1 Proteinase Inhibitors Derived from Penicillin Analytical Biochemistry ·Norman M. Gray,Megan M. Pickersgill,N. Cammack,Kevin N. Cobley,Duncan S. Holmes,David C. Humber,David Orr,Charles R. Penn,Richard Pötter,Shalom Madar,Gordon G. Weingarten,Richard C. Bethell	1994	0
8	A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships Journal of Medicinal Chemistry ·David C. Humber,Mark J. Bamford,Richard C. Bethell,N. Cammack,Kevin N. Cobley,Sandhya Godshe,Norman M. Gray,Michael M. Hann,David Orr	1993	15
9	Synthesis and anti-HIV-1 activity of a series of imidazo[1,5-b]pyridazines Journal of Medicinal Chemistry ·최준서,V RUIZ,N. Cammack,川崎慎司,Alexander Tsang,ポラスグループ,岡山明子,敏雄片桐,Zainab M. Al Balushi	1993	66
10	Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere Journal of Medicinal Chemistry ·David S. Holmes,Richard C. Bethell,N. Cammack,Ayelet Shles,John R. Kitchin,Peter McMeekin,Supriya Subhash Maske,David Orr,Ernst Friedman	1993	19
11	High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase Antimicrobial Agents and Chemotherapy ·Charles A. Boucher,N. Cammack,P Schipper,Rob Schuurman,R. Kozik,Mark A. Wainberg,J. M. Cameron	1993	263
12	Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase Journal of Medicinal Chemistry ·David C. Humber,N. Cammack,Jonathan A. Coates,Kevin N. Cobley,David Orr,Richard Storer,Gordon G. Weingarten,Malcolm Weir	1992	26
13	Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine Biochemical Pharmacology ·N. Cammack,R. Kozik,Fang-qin XU,P. Beneyto Martin,Richard Boehme,Jonathan A. Coates,Charles R. Penn,J. M. Cameron	1992	98
14	Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources Journal of Medical Virology ·Glynis Dunn,Norman Begg,N. Cammack,Philip D. Minor	1990	75
15	Molecular biology and the control of viral vaccines FEMS Microbiology Letters ·Philip D. Minor,Andrew Macadam,N. Cammack,G. Dunn,Jeffrey W. Almond	1990	10
16	Use of a Monoclonal Antibody Specific for Wild-type Yellow Fever Virus to Identify a Wild-type Antigenic Variant in 17D Vaccine Pools Journal of General Virology ·Ernest A. Gould,A. Buckley,Patricia A. Cane,S. Higgs,N. Cammack	1989	26
17	Reversion of the attenuated and temperature-sensitive phenotypes of the sabin type 3 strain of poliovirus in vaccinees Virology ·Andrew Macadam,Caroline Arnold,A.D. Green,A. John,S.A. Marsden,F. Taffs,P. Reeve,Nobuyuki Hamada,岡田雅史,J. W. Almond,N. Cammack,Philip D. Minor	1989	93
18	Intertypic genomic rearrangements of poliovirus strains in vaccinees Virology ·N. Cammack,K Brennan-Shuey,G. Dunn,Vilas Y. Rajopadhye,Iben Christensen	1988	76
19	Examination of the Immunological Relationships between Flaviviruses Using Yellow Fever Virus Monoclonal Antibodies Journal of General Virology ·Ernest A. Gould,A. Buckley,N. Cammack,Alan D.T. Barrett,J. C. S. Clegg,Ricardo Ishak,M. G. R. Varma	1985	113
20	Single Mutations at Many Sites within the DNA Polymerase Locus of Herpes Simplex Viruses Can Confer Hypersensitivity to Aphidicolin and Resistance to Phosphonoacetic Acid Journal of General Virology ·R. W. Honess,D. J. M. Purifoy,David M. Young,David P. Bryant,N. Cammack,Peter O’Hare	1984	31

About N. Cammack

N. Cammack is a scholar working on Virology, Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (16 papers), HIV Research and Treatment (12 papers), Mosquito-borne diseases and control (8 papers), Viral Infections and Immunology Research (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Viral Infections and Vectors (5 papers), Plant Virus Research Studies (5 papers) and Virology and Viral Diseases (4 papers). The work is most often cited by research in Virology (815 citations), Infectious Diseases (1.6k citations), Hepatology (146 citations), Cardiology and Cardiovascular Medicine (369 citations) and Epidemiology (502 citations). N. Cammack has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include J. M. Cameron, Ernest A. Gould, A. Buckley, Mark A. Wainberg, Charles A. Boucher, Charles R. Penn, Philip D. Minor, Alan D.T. Barrett, Jonathon Alexis Coates and G. Dunn. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of General Virology, Antimicrobial Agents and Chemotherapy, Virology and Nature Reviews Drug Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact